<table border="1"><tr><th>Surname</th><td><ul><li>Etravirin</li></ul></td></tr><tr><th>Other names</th><td><ul><li>4-[6-amino-5-brom-2-(4-cyanophenylamino)pyrimidin-4-yloxy]-3,5-dimethylbenzonitrile (IUPAC) | TMC-125</li></ul></td></tr><tr><th>Sum formula</th><td><ul><li>C | 20 | H | 15 | BrN | 6 | O</li></ul></td></tr><tr><th>EC number</th><td><ul><li>682-331-6</li></ul></td></tr><tr><th>ECHA-InfoCard</th><td><ul><li>100.207.546</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>193962</li></ul></td></tr><tr><th>ChemSpider</th><td><ul><li>168313</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB06414</li></ul></td></tr><tr><th>Wikidata</th><td><ul><li>Q414762</li></ul></td></tr><tr><th>ATC-Code</th><td><ul><li>J05 | AG04</li></ul></td></tr><tr><th>Class of active substances</th><td><ul><li>Virustatics, non-nucleoside reverse transcriptionase inhibitors</li></ul></td></tr><tr><th>Mechanism</th><td><ul><li>Non-competitive inhibition of reverse transcriptase</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>435.28 g·mol | −1</li></ul></td></tr><tr><th>GHS hazard labelling | Attention</th><td><ul><li></li></ul></td></tr><tr><th>H- and P-seeds</th><td><ul><li>H | 302 | ‐ | 413</li></ul></td></tr><tr><th>General</th><td><ul><li>French name | Etravirin | Other names | 4-[6-Amino-5-brom-2-(4-cyanophenylamino)pyrimidin-4-yloxy]-3,5-dimethylbenzonitril (IUPAC) | TMC-125 | Sum formula | C | 20 | H | 15 | BrN | 6 | O</li></ul></td></tr><tr><th>External Identifiers/Databases</th><td><ul><li>CAS Number | 269055-15-4 | EC Number | 682-331-6 | ECHA InfoCard | 100.207.546 | PubChem | 193962 | ChemSpider | 168313 | DrugBank | DB06414 | Wikidata | Q414762 | CAS Number | 269055-15-4 | EC Number | 682-331-6 | ECHA InfoCard | 100.207.546 | PubChem | 193962 | ChemSpider | 168313 | DrugBank | DB06414 | Wikidata | Q414762 | CAS Number | 269055-15-4 | EC Number | 682-331-6 | ECHA InfoCard | 100.207.546 | PubChem</li></ul></td></tr><tr><th>Drug data</th><td><ul><li>ATC code | J05 | AG04 | active class | virulent drug, nonnuclear reverse transcriptase inhibitors | active mechanism | non-competitive inhibition of reverse transcriptase</li></ul></td></tr><tr><th>Properties</th><td><ul><li>Molar mass | 435.28 g·mol | −1</li></ul></td></tr><tr><th>GHS hazard labelling</th><td><ul><li></li></ul></td></tr><tr><th>Safety Notes</th><td><ul><li>Please note the exemption from the labelling obligation for medicines, medical products, cosmetics, foods and feedingstuffs | H- and P-seats | H | 302 | ‐ | 413 | P |? | Please note the exemption from the labelling obligation for medicines, medical products, cosmetics, foods and feedingstuffs | H- and P-seats | H | 302 | ‐ | 413 | P |? | SI units are used as far as possible and commonly used. If not otherwise noted, the data indicated apply under standard conditions.</li></ul></td></tr></table>